论文部分内容阅读
目的:探讨和分析小儿咳嗽变异性哮喘采取药物联合治疗的临床疗效及价值。方法:选取咳嗽变异性哮喘患儿90例分成对照组和观察组;对照组患儿给予盐酸丙卡特罗进行治疗;观察组给予盐酸丙卡特罗联合孟鲁司特进行治疗,观察和对比两组患儿临床治疗疗效。结果:观察组45例患儿,总治疗有效率为95.6%;对照组45例患儿,总治疗有效率为75.6%,两组间在痊愈率和总治疗有效率等指标对比上有显著性差异和统计学意义(P<0.05)。结论:对小儿咳嗽变异性哮采取盐酸丙卡特罗联合孟鲁司特进行治疗,治疗疗效好,有助于患儿哮喘症状的改善或缓解,值得在临床上进行推广。
Objective: To investigate and analyze the clinical efficacy and value of combined treatment of children with cough variant asthma. Methods: Ninety children with cough variant asthma were divided into control group and observation group. The control group was treated with procaterol hydrochloride. The observation group was treated with procaterol hydrochloride and montelukast. The observation and comparison of two groups Clinical efficacy of treatment in children. Results: The observation group of 45 patients, the total effective rate was 95.6%; control group of 45 patients, the total effective rate was 75.6%, between the two groups in the cure rate and the total effective rate of treatment was significant Difference and statistical significance (P <0.05). Conclusion: Pediatric cough variant asthma taking procaterol hydrochloride combined with montelukast for treatment, the treatment effect is good, help to improve or alleviate the symptoms of asthma in children, it is worth in the clinical promotion.